{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:41Z","timestamp":1790916821523,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"vor","delay-in-days":143,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101262","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:20:09Z","timestamp":1779751209000},"page":"101262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tolerability and effectiveness of definitive chemoradiotherapy in locally advanced lung cancer patients with combined pulmonary fibrosis and emphysema"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0376-3962","authenticated-orcid":false,"given":"Kana","family":"Fujimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kiyokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Natori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoomi","family":"Okamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Iwashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101262_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108541","article-title":"Chemoradiotherapy efficacy in patients with stage III non-small cell lung cancer (NSCLC): a prognostic clinical and biomarker-based model","volume":"203","author":"Vaes","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ctarc.2026.101262_bib0002","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.21.02528","article-title":"Management of stage III non-small-cell lung cancer: ASCO guideline","volume":"40","author":"Daly","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101262_bib0003","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.23.01435","article-title":"Systemic therapy for small-cell lung cancer: ASCO-Ontario Health (Cancer Care Ontario) guideline","volume":"41","author":"Khurshid","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101262_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2026.106070","article-title":"Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC","volume":"11","author":"Girard","year":"2026","journal-title":"ESMO Open."},{"key":"10.1016\/j.ctarc.2026.101262_bib0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non\u2013small-cell lung cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101262_bib0006","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/oncolo\/oyac226","article-title":"Management of lung cancer in the patient with interstitial lung disease","volume":"28","author":"Frank","year":"2023","journal-title":"Oncologist."},{"key":"10.1016\/j.ctarc.2026.101262_bib0007","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/1759-7714.14418","article-title":"Treatment outcomes of patients with stage III non-small cell lung cancer and interstitial lung diseases receiving intensity-modulated radiation therapy: a single-center experience of 85 cases","volume":"13","author":"Wu","year":"2022","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.ctarc.2026.101262_bib0008","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.radonc.2020.11.020","article-title":"Idiopathic pulmonary fibrosis: current knowledge, future perspectives and its importance in radiation oncology","volume":"155","author":"T\u00fcrkkan","year":"2021","journal-title":"RadiOther Oncol."},{"key":"10.1016\/j.ctarc.2026.101262_bib0009","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/j.clon.2022.01.043","article-title":"Is thoracic radiotherapy an absolute contraindication for treatment of lung cancer patients with interstitial lung disease? A systematic review","volume":"34","author":"Saha","year":"2022","journal-title":"Clin. Oncol. (R. Coll. Radiol)"},{"key":"10.1016\/j.ctarc.2026.101262_bib0010","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.ijrobp.2024.01.217","article-title":"Pneumonitis risk after chemoradiotherapy with and without immunotherapy in patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis","volume":"119","author":"Han","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2026.101262_bib0011","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ijrobp.2023.09.050","article-title":"Pneumonitis after chemoradiotherapy and adjuvant durvalumab in stage III non-small cell lung cancer","volume":"118","author":"Edwards","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2026.101262_bib0012","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.05.00021005","article-title":"Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity","volume":"26","author":"Cottin","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ctarc.2026.101262_bib0013","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1164\/rccm.202206-1041ST","article-title":"Syndrome of combined pulmonary fibrosis and emphysema: an official ATS\/ERS\/JRS\/ALAT research statement","volume":"206","author":"Cottin","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ctarc.2026.101262_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12031100","article-title":"The impact of lung cancer in patients with combined pulmonary fibrosis and emphysema (CPFE)","volume":"12","author":"Feng","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ctarc.2026.101262_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11061636","article-title":"Combined pulmonary fibrosis and emphysema: comparative evidence on a complex condition","volume":"11","author":"Calaras","year":"2023","journal-title":"Biomedicines."},{"key":"10.1016\/j.ctarc.2026.101262_bib0016","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.mayocp.2023.05.002","article-title":"Combined pulmonary fibrosis and emphysema: a narrative review","volume":"98","author":"Nemoto","year":"2023","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ctarc.2026.101262_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062236","article-title":"Prognosis of acute exacerbation in idiopathic pulmonary fibrosis with pulmonary emphysema: a retrospective cohort study in Japan","volume":"12","author":"Horio","year":"2022","journal-title":"BMJ Open."},{"key":"10.1016\/j.ctarc.2026.101262_bib0018","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/COPD.S286360","article-title":"Combined pulmonary fibrosis and emphysema (CPFE) clinical features and management","volume":"Volume 16","author":"Hage","year":"2021","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.ctarc.2026.101262_bib0019","doi-asserted-by":"crossref","DOI":"10.1177\/17534666211017050","article-title":"An increased risk of lung cancer in combined pulmonary fibrosis and emphysema patients with usual interstitial pneumonia compared with patients with idiopathic pulmonary fibrosis alone: a systematic review and meta-analysis","volume":"15","author":"Chen","year":"2021","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.ctarc.2026.101262_bib0020","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4046\/trd.2021.0141","article-title":"Chronic obstructive pulmonary disease combined with interstitial lung disease","volume":"85","author":"Choi","year":"2022","journal-title":"Tuberc. Respir. Dis. (Seoul)"},{"key":"10.1016\/j.ctarc.2026.101262_bib0021","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/JTO.0000000000000209","article-title":"Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 western patients","volume":"9","author":"Girard","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ctarc.2026.101262_bib0022","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an Update) and progressive Pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ctarc.2026.101262_bib0023","article-title":"The extent of honeycombing on computed tomography cannot predict the treatment outcome of patients with acute exacerbations of interstitial lung disease","volume":"2021","author":"Nishikawa","year":"2021","journal-title":"Can. Respir. J."},{"key":"10.1016\/j.ctarc.2026.101262_bib0024","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00127-2023","article-title":"Mortality surrogates in combined pulmonary fibrosis and emphysema","volume":"63","author":"Zhao","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ctarc.2026.101262_bib0025","series-title":"Common Terminology Criteria For Adverse Events (CTCAE) Version 5.0","year":"2017"},{"key":"10.1016\/j.ctarc.2026.101262_bib0026","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.rmed.2018.12.003","article-title":"Combined pulmonary fibrosis and emphysema as a clinicoradiologic entity: characterization of presenting lung fibrosis and implications for survival","volume":"146","author":"Alsumrain","year":"2019","journal-title":"Respir. Med."},{"key":"10.1016\/j.ctarc.2026.101262_bib0027","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.rxeng.2022.10.008","article-title":"Smoking-related interstitial lung disease","volume":"64","author":"Serrano Gotarredona","year":"2022","journal-title":"Radiologia (Engl. Ed)"},{"key":"10.1016\/j.ctarc.2026.101262_bib0028","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ctarc.2026.101262_bib0029","article-title":"Meta-analysis: clinical features and treatments of lung cancer in combined pulmonary fibrosis and emphysema","volume":"40","author":"Zhou","year":"2023","journal-title":"Sarcoidosis. Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.ctarc.2026.101262_bib0030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1440-1843.2010.01907.x","article-title":"The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer","volume":"16","author":"Usui","year":"2011","journal-title":"Respirology."},{"key":"10.1016\/j.ctarc.2026.101262_bib0031","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3892\/mco.2016.954","article-title":"Clinical features and outcomes of patients with lung cancer as well as combined pulmonary fibrosis and emphysema","volume":"5","author":"Otsuka","year":"2016","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101262_bib0032","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1093\/ejcts\/ezu384","article-title":"Prognostic significance of combined pulmonary fibrosis and emphysema in patients with resected non-small-cell lung cancer: a retrospective cohort study","volume":"46","author":"Kumagai","year":"2014","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"10.1016\/j.ctarc.2026.101262_bib0033","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1164\/rccm.202303-0395OC","article-title":"Clonal somatic mutations in chronic lung diseases are associated with reduced lung function","volume":"208","author":"Yun","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ctarc.2026.101262_bib0034","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1002\/cam4.858","article-title":"The histological characteristics and clinical outcomes of lung cancer in patients with combined pulmonary fibrosis and emphysema","volume":"5","author":"Zhang","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.ctarc.2026.101262_bib0035","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-024-03088-5","article-title":"Analysis of clinical characteristics and prognosis of lung cancer patients with CPFE or COPD: a retrospective study","volume":"24","author":"Wei","year":"2024","journal-title":"BMC. Pulm. Med."},{"key":"10.1016\/j.ctarc.2026.101262_bib0036","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.21037\/tcr-22-1526","article-title":"Immunotherapy for combined pulmonary fibrosis and emphysema with advanced lung cancer: two case reports and a concise review","volume":"11","author":"Tan","year":"2022","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101262_bib0037","article-title":"Efficacy and safety of immune checkpoint inhibitors in lung cancer patients with combined pulmonary fibrosis and emphysema","volume":"64","author":"Chin","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ctarc.2026.101262_bib0038","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/25785826.2021.1997268","article-title":"Radiotherapy driven immunomodulation of the tumor microenvironment and its impact on clinical outcomes: a promising new treatment paradigm","volume":"45","author":"Mahmood","year":"2022","journal-title":"Immunol. Med."},{"key":"10.1016\/j.ctarc.2026.101262_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70402","article-title":"Combination immunotherapy with radiotherapy in non-small cell lung cancer: a review of evidence","volume":"13","author":"Burr","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.ctarc.2026.101262_bib0040","article-title":"Synergistic effects of radiotherapy and immunotherapy: improving oncological outcomes","volume":"17","author":"Chen","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101262_bib0041","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10637-021-01191-6","article-title":"Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer","volume":"40","author":"Nishimura","year":"2022","journal-title":"Invest. New Drugs"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:59:39Z","timestamp":1790913579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226001735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":41,"alternative-id":["S2468294226001735"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101262","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tolerability and effectiveness of definitive chemoradiotherapy in locally advanced lung cancer patients with combined pulmonary fibrosis and emphysema","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101262"}}